Abstract
INTRODUCTION Alzheimer’s disease affects spatial abilities that are often overlooked in standard cognitive screening tools. We assessed whether the spatial navigation tasks in the Spatial Performance Assessment for Cognitive Evaluation (SPACE) can complement existing tools such as the Montreal Cognitive Assessment (MoCA).
METHODS 348 participants aged 21-76 completed the MoCA, SPACE, and sociodemographic- health questionnaires. Regressions were used to predict MoCA scores with risk factors and SPACE tasks as predictors. We also conducted a factor analysis to investigate the relationships among SPACE tasks and the MoCA.
RESULTS Regressions revealed significant effects of age, gender, and SPACE tasks. No risk factors for dementia predicted MoCA scores. The factor analysis revealed that MoCA and perspective taking contributed to a separate factor from other navigation tasks in SPACE. Normative data for SPACE are provided.
DISCUSSION Our findings highlight the importance of navigation tasks for cognitive assessment and the early detection of cognitive impairment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research was conducted at the Future Health Technologies programme which was established collaboratively between ETH Zurich and the National Research Foundation Singapore. This research is supported by the National Research Foundation, Prime Minister’s Office, Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme and ETH Zurich.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for this study was granted by the Parkway Independent Ethics Committee (PIEC/2022/010) and the ETH Zurich Ethics Commission (EK 2021-N-193). Written informed consent was obtained from all participants prior to their involvement in the study. All procedures adhered to the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data supporting this article may be available upon request and pending approval from the ethics committees in Singapore and ETH Zurich.
